arrow down

Closing the AD Gap

Introducing a New Global Survey

Right now, the majority of doctors assess AD from a physical standpoint. While physical signs and symptoms are important to look at, kids and teens, caregivers and families know there is often more going on – beyond the skin.

It’s time to not only reveal any gaps in understanding around the unseen impacts of AD, but actively seek to close them.

“With AD, there are ripple effects beyond the skin. For example, itch can impact a child’s sleep, which can impact the family’s sleep, which can impact school, work, relationships and more. These impacts can’t be ignored.”

Korey Capozza, Founder of Global Parents for Eczema Research, U.S.A.

That’s why Regeneron and Sanofi Genzyme commissioned the Atopic Dermatitis Global Adolescent & Pediatric Survey, or AD-GAP. A unique global study across 13 countries designed to explore the complete impact of AD on the lives of kids and teens.

13 Countries. 3 Groups. 1 Survey.

Far-Reaching AD Impacts

AD impacts up to 1 in every 5 children globally, with up to 40% estimated to have the moderate-to-severe disease1-8. It’s a long-term, often unpredictable disease, that can impact kids and teens living with it, and those around them, in various ways. So when it comes to managing life with AD, different people can be on different pages.

Doctors and specialists often focus on symptoms and treatment. Parents and caregivers often focus on their day-to-day well-being and routines. Kids and teens just want to focus on living their lives.

By taking into account all of these perspectives, we have an opportunity to better understand the full impact of AD, and bring positive change to the lives of kids and teens living with this chronic disease, as well as their families.

“By pausing to consider the different experiences between these three distinct groups of people, we can uncover the gaps in conversation. We hope, in time, to close these gaps through better dialogue—enabling the best AD care possible for kids and teens.”

Dr Stephan Weidinger, Professor and Vice Director, Department of Dermatology and Allergy, University Hospital Kiel, Germany

Through this research, we aim to uncover a deeper understanding of the impacts AD has on families, social lives, school, hobbies and emotional and psychological wellbeing.

Through this deeper understanding, we hope to shed light on new ways to optimise care for current - and future - AD communities.

Stay tuned for more information and findings from the survey later this year.